|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
US3949064A
(en)
|
1973-10-26 |
1976-04-06 |
Baxter Laboratories, Inc. |
Method of detecting antigens or antibodies
|
|
US4174384A
(en)
|
1975-06-30 |
1979-11-13 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4367110A
(en)
|
1979-07-02 |
1983-01-04 |
Toppan Printing Co. |
Decorative laminate and a manufacturing method therefor
|
|
US4372945A
(en)
|
1979-11-13 |
1983-02-08 |
Likhite Vilas V |
Antigen compounds
|
|
US4452901A
(en)
|
1980-03-20 |
1984-06-05 |
Ciba-Geigy Corporation |
Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
|
|
US4338298A
(en)
|
1980-04-04 |
1982-07-06 |
Endowment And Research Foundation At Montana State University |
Vaccine for passive immunization against enteric colibacillosis and method of use
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
IL61904A
(en)
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
US4596792A
(en)
|
1981-09-04 |
1986-06-24 |
The Regents Of The University Of California |
Safe vaccine for hepatitis containing polymerized serum albumin
|
|
NL8200523A
(nl)
|
1982-02-11 |
1983-09-01 |
Univ Leiden |
Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna.
|
|
US4748018A
(en)
|
1984-02-07 |
1988-05-31 |
Stolle Research & Development Corp. |
Method of passive immunization of mammals using avian antibody
|
|
JPS5938877A
(ja)
|
1982-08-30 |
1984-03-02 |
Musashi Eng Kk |
紙葉判別方法
|
|
US4599230A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
US5221605A
(en)
|
1984-10-31 |
1993-06-22 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US5310687A
(en)
|
1984-10-31 |
1994-05-10 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US5238808A
(en)
|
1984-10-31 |
1993-08-24 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US4608251A
(en)
|
1984-11-09 |
1986-08-26 |
Pitman-Moore, Inc. |
LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4601903A
(en)
|
1985-05-01 |
1986-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US5084269A
(en)
|
1986-11-06 |
1992-01-28 |
Kullenberg Fred W |
Adjuvant for dose treatment with antigens
|
|
AU622104B2
(en)
|
1987-03-11 |
1992-04-02 |
Sangtec Molecular Diagnostics Ab |
Method of assaying of nucleic acids, a reagent combination and kit therefore
|
|
US4952500A
(en)
|
1988-02-01 |
1990-08-28 |
University Of Georgia Research Foundation, Inc. |
Cloning systems for Rhodococcus and related bacteria
|
|
WO1989009284A1
(en)
|
1988-03-24 |
1989-10-05 |
University Of Iowa Research Foundation |
Catalytic hybridization systems for the detection of nucleic acid sequences based on their activity as cofactors in catalytic reactions in which a complementary labeled nucleic acid probe is cleaved
|
|
US5858652A
(en)
|
1988-08-30 |
1999-01-12 |
Abbott Laboratories |
Detection and amplification of target nucleic acid sequences
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
SE8901687D0
(sv)
|
1989-05-11 |
1989-05-11 |
Alfa Laval Agri Int |
Fibronectin binding protein as well as its preparation
|
|
US5302523A
(en)
|
1989-06-21 |
1994-04-12 |
Zeneca Limited |
Transformation of plant cells
|
|
US7705215B1
(en)
|
1990-04-17 |
2010-04-27 |
Dekalb Genetics Corporation |
Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
|
|
US5550318A
(en)
|
1990-04-17 |
1996-08-27 |
Dekalb Genetics Corporation |
Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
|
|
US5322783A
(en)
|
1989-10-17 |
1994-06-21 |
Pioneer Hi-Bred International, Inc. |
Soybean transformation by microparticle bombardment
|
|
US5484956A
(en)
|
1990-01-22 |
1996-01-16 |
Dekalb Genetics Corporation |
Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
US5199942A
(en)
|
1991-06-07 |
1993-04-06 |
Immunex Corporation |
Method for improving autologous transplantation
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
US5610042A
(en)
|
1991-10-07 |
1997-03-11 |
Ciba-Geigy Corporation |
Methods for stable transformation of wheat
|
|
US5620896A
(en)
|
1992-03-23 |
1997-04-15 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
WO1993018784A1
(en)
|
1992-03-26 |
1993-09-30 |
Microcarb, Inc. |
Monospecific polyclonal antibodies to shiga-like toxins
|
|
EP1983056A1
(en)
|
1992-07-07 |
2008-10-22 |
Japan Tobacco Inc. |
Method for transforming monocotyledons
|
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
|
HUT70467A
(en)
|
1992-07-27 |
1995-10-30 |
Pioneer Hi Bred Int |
An improved method of agrobactenium-mediated transformation of cultvred soyhean cells
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
GB9222888D0
(en)
|
1992-10-30 |
1992-12-16 |
British Tech Group |
Tomography
|
|
US5846709A
(en)
|
1993-06-15 |
1998-12-08 |
Imclone Systems Incorporated |
Chemical process for amplifying and detecting nucleic acid sequences
|
|
FR2708288B1
(fr)
|
1993-07-26 |
1995-09-01 |
Bio Merieux |
Procédé d'amplification d'acides nucléiques par transcription utilisant le déplacement, réactifs et nécessaire pour la mise en Óoeuvre de ce procédé.
|
|
CA2171942C
(en)
|
1993-09-22 |
2010-12-14 |
Andrew Lees |
Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
|
|
US5928905A
(en)
|
1995-04-18 |
1999-07-27 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US5648240A
(en)
|
1994-05-24 |
1997-07-15 |
Texas A&M University |
MHC II analog from Staphylococcus aureus
|
|
AU707391B2
(en)
|
1994-05-28 |
1999-07-08 |
Tepnel Medical Limited |
Producing copies of nucleic acids
|
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
|
US5942391A
(en)
|
1994-06-22 |
1999-08-24 |
Mount Sinai School Of Medicine |
Nucleic acid amplification method: ramification-extension amplification method (RAM)
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
US6008341A
(en)
|
1994-08-22 |
1999-12-28 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
S. aureus fibrinogen binding protein gene
|
|
US5871986A
(en)
|
1994-09-23 |
1999-02-16 |
The General Hospital Corporation |
Use of a baculovirus to express and exogenous gene in a mammalian cell
|
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5935825A
(en)
|
1994-11-18 |
1999-08-10 |
Shimadzu Corporation |
Process and reagent for amplifying nucleic acid sequences
|
|
US6770278B1
(en)
|
1994-12-02 |
2004-08-03 |
Central Biomedia, Inc. |
Methods of making and using immunoglobulin (Ig) compositions
|
|
US5548066A
(en)
|
1994-12-02 |
1996-08-20 |
Central Biomedia, Inc. |
Failure of passive transfer immune serum and method of making same
|
|
US5843650A
(en)
|
1995-05-01 |
1998-12-01 |
Segev; David |
Nucleic acid detection and amplification by chemical linkage of oligonucleotides
|
|
EP0857214A1
(en)
|
1995-10-16 |
1998-08-12 |
Smithkline Beecham Plc |
Novel saliva binding protein
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
US6737248B2
(en)
|
1996-01-05 |
2004-05-18 |
Human Genome Sciences, Inc. |
Staphylococcus aureus polynucleotides and sequences
|
|
US5612473A
(en)
|
1996-01-16 |
1997-03-18 |
Gull Laboratories |
Methods, kits and solutions for preparing sample material for nucleic acid amplification
|
|
US5928906A
(en)
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
|
AU3126097A
(en)
|
1996-05-16 |
1997-12-05 |
The Texas A & M University System |
Collagen binding protein compositions and methods of use
|
|
US5939291A
(en)
|
1996-06-14 |
1999-08-17 |
Sarnoff Corporation |
Microfluidic method for nucleic acid amplification
|
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
|
US6294177B1
(en)
|
1996-09-11 |
2001-09-25 |
Nabi |
Staphylococcus aureus antigen-containing whole cell vaccine
|
|
US5849546A
(en)
|
1996-09-13 |
1998-12-15 |
Epicentre Technologies Corporation |
Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
|
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
|
EP0958373A4
(en)
|
1996-10-23 |
2001-11-28 |
American Home Prod |
Vaccines.
|
|
US5849497A
(en)
|
1997-04-03 |
1998-12-15 |
The Research Foundation Of State University Of New York |
Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker
|
|
US6610293B1
(en)
|
1997-06-16 |
2003-08-26 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
|
|
US5866366A
(en)
|
1997-07-01 |
1999-02-02 |
Smithkline Beecham Corporation |
gidB
|
|
US5916776A
(en)
|
1997-08-27 |
1999-06-29 |
Sarnoff Corporation |
Amplification method for a polynucleotide
|
|
US6756361B1
(en)
|
1997-10-14 |
2004-06-29 |
Nabi |
Enterococcus antigens and vaccines
|
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
|
US5932451A
(en)
|
1997-11-19 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Method for unbiased mRNA amplification
|
|
IL122829A
(en)
*
|
1997-12-31 |
2000-06-29 |
Maabarot Products Ltd |
Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
|
|
ATE443768T1
(de)
|
1998-07-10 |
2009-10-15 |
U S Medical Res Inst Of Infect |
Impfstoff gegen staphylokokken-vergiftung
|
|
EP1121149A4
(en)
|
1998-08-31 |
2002-03-20 |
Inhibitex Inc |
IMMUNOTHERAPY METHOD FOR STAPHYLOCOCCAL INFECTIONS INCLUDING DONOR SELECTION AND DONOR STIMULATION
|
|
CN1283798C
(zh)
|
1998-08-31 |
2006-11-08 |
都柏林伊丽莎白女皇神学院 |
凝固酶阴性葡萄球菌的多肽及多核苷酸
|
|
WO2000015238A1
(en)
|
1998-09-14 |
2000-03-23 |
Nabi |
COMPOSITIONS OF β-GLUCANS AND SPECIFIC IGIV
|
|
AU769539B2
(en)
|
1999-01-29 |
2004-01-29 |
Zoetis Services Llc |
Adjuvants for use in vaccines
|
|
US6936258B1
(en)
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
AU1478301A
(en)
|
1999-11-09 |
2001-06-06 |
Glaxo Group Limited |
Staphylococcus epidermidis nucleic acids and proteins
|
|
ATE413191T1
(de)
|
1999-12-03 |
2008-11-15 |
Celltech Chiroscience Ltd |
Verwendung of interleukin-1 mutein als impfstoffadjuvans
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
SE0000514D0
(sv)
|
2000-02-17 |
2000-02-17 |
Biostapro Ab |
A 52 kDa protein from coagulase negative staphylococci and fragments
|
|
WO2001070955A2
(en)
*
|
2000-03-21 |
2001-09-27 |
Elitra Pharmaceuticals, Inc. |
Identification of essential genes in prokaryotes
|
|
GB0014907D0
(en)
|
2000-06-20 |
2000-08-09 |
Univ Sheffield |
Antigenic polypeptides
|
|
SE0003573D0
(sv)
*
|
2000-10-04 |
2000-10-04 |
Bengt Guss |
Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
|
|
ATE317267T1
(de)
|
2000-11-07 |
2006-02-15 |
Immunovaccine Technologies Inc |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
|
AT410798B
(de)
*
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
WO2002074324A1
(en)
|
2001-03-15 |
2002-09-26 |
The Texas A & M University System |
Collagen-binding adhesin from staphylococcus epidermidis and method of use
|
|
AU2002306849A1
(en)
*
|
2001-03-21 |
2002-10-08 |
Elitra Pharmaceuticals, Inc. |
Identification of essential genes in microorganisms
|
|
GB0107661D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
CA2453937C
(en)
*
|
2001-08-02 |
2013-05-14 |
University Of Sheffield |
Antigenic polypeptides
|
|
US20040029129A1
(en)
*
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
|
US7115264B2
(en)
|
2001-11-05 |
2006-10-03 |
Inhibitex |
Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
|
|
ATE419005T1
(de)
|
2001-12-11 |
2009-01-15 |
Merck & Co Inc |
Staphylococcus aureus exopolysaccharid und verfahren
|
|
NZ539153A
(en)
|
2002-11-12 |
2006-11-30 |
Brigham & Womens Hospital |
Polysaccharide vaccine for staphylococcal infections
|
|
WO2004043407A2
(en)
|
2002-11-12 |
2004-05-27 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating staphylococcal infections
|
|
KR101505496B1
(ko)
*
|
2004-09-22 |
2015-03-25 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
스태필로코쿠스에 대한 예방접종에 사용하기 위한 면역원성 조성물
|
|
KR100654455B1
(ko)
*
|
2005-05-26 |
2006-12-06 |
삼성전자주식회사 |
확장형 자막 파일을 이용하여 부가정보를 제공하는 장치 및방법
|
|
KR20070082442A
(ko)
*
|
2006-02-16 |
2007-08-21 |
정재욱 |
폴더형 개인휴대단말기
|
|
KR100771584B1
(ko)
*
|
2006-02-16 |
2007-10-30 |
다이노나(주) |
메치실린-내성 황색포도상구균 특이적 항체, 상기 항체를이용하는 메치실린-내성 황색포도상구균 탐지방법, 및탐지키트
|
|
AR060187A1
(es)
*
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
|
KR101541383B1
(ko)
|
2006-03-30 |
2015-08-03 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
면역원성 조성물
|
|
US9526774B1
(en)
*
|
2006-11-06 |
2016-12-27 |
Microvax, Llc |
Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus
|
|
GB0700136D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
US9181329B2
(en)
*
|
2007-08-31 |
2015-11-10 |
The University Of Chicago |
Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
|
|
WO2010014304A1
(en)
*
|
2008-07-29 |
2010-02-04 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
AU2009302582A1
(en)
*
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
|
|
SI3281947T1
(sl)
*
|
2009-04-03 |
2020-07-31 |
The University Of Chicago |
Sestave in metode v zvezi z variantami proteina A (SPA)
|
|
DK2510947T3
(en)
*
|
2009-04-14 |
2016-03-21 |
Glaxosmithkline Biolog Sa |
Compositions for Immunization against Staphylococcus aureus.
|
|
EP2459586B1
(fr)
*
|
2009-06-10 |
2014-08-13 |
InGen Biosciences |
Antigenes proteiques destines au serodiagnostic des infections a staphylococcus aureus notamment sur protheses osteo-articulaires
|
|
US20140037650A1
(en)
*
|
2009-07-24 |
2014-02-06 |
University Of Chicago |
Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
|
|
EP2550529B1
(en)
*
|
2010-03-23 |
2021-11-17 |
Iogenetics, LLC. |
Bioinformatic processes for determination of peptide binding
|
|
FR2957821B1
(fr)
|
2010-03-24 |
2014-08-29 |
Inst Francais Du Petrole |
Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives
|
|
JP2013523818A
(ja)
*
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
|
|
CA2803298C
(en)
*
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
JP5793194B2
(ja)
*
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
|
EP2694534B1
(en)
*
|
2011-04-08 |
2018-06-20 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
|
US8945588B2
(en)
*
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
AU2012296576B2
(en)
*
|
2011-08-15 |
2017-09-07 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein a
|
|
US20150044251A1
(en)
*
|
2011-12-23 |
2015-02-12 |
Novartis Ag |
Stable compositions for immunising against staphylococcus aureus
|
|
WO2013162751A1
(en)
*
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
|
|
WO2013162746A1
(en)
*
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
|
WO2014179744A1
(en)
*
|
2013-05-03 |
2014-11-06 |
The University Of Chicago |
Staphylococcus live cell vaccines
|
|
AU2015209140B2
(en)
*
|
2014-01-24 |
2020-01-02 |
William R. Church |
Antibody specific to Staphylococcus aureus, therapeutic method and detection method using same
|
|
PL236568B1
(pl)
*
|
2014-08-31 |
2021-01-25 |
Inst Biochemii I Biofizyki Polskiej Akademii Nauk |
Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA
|
|
DK3332023T3
(da)
*
|
2015-08-06 |
2023-07-10 |
Ares Genetics Gmbh |
Genetisk test til alignment-fri forudsigelse af mikroorganismers resistens over for antimikrobielle midler
|
|
US11214600B2
(en)
*
|
2016-02-12 |
2022-01-04 |
The University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease
|